Insulin resistance in patients with RA may be attributed to the increase in proinflammatory cytokines like TNF-α and IL-6 and the extensive use of GCs during the pandemic, especially for patients with low SpO2 levels [42]. This evidence concerns the gene IL6 and rheumatoid arthritis.